Butterfly Network CEO Joe DeVivo returns to explain how ultrasound-on-a-chip became a semiconductor platform others build on, the path from demo to FDA clearance, and a future where imaging comes to the patient.
AliveCor founder Dr. David Albert on turning the smartphone into a clinical-grade ECG, the new Kardia 12L, and how an AI engine trained on more than a million ECGs can flag arrhythmias and heart attacks.
Arrive Health CEO Kyle Kiser on closing the information gap between providers, payers and patients by putting real-time prescription pricing and coverage data directly into the clinical workflow.
Raffi Krikorian, CTO of Emerson Collective and former VP of engineering at Twitter, on why the window to put guardrails on AI is closing fast — and what that means for technology, politics and society.
ActiveLoop CEO David Buniatyan on building the data infrastructure behind generative AI, and what it will take for AI-designed molecules to translate into better medicines.
Caristo Diagnostics on an AI test that reads CT scans for inflammation around the coronary arteries — the warning sign radiologists miss in most patients at high risk of a heart attack.
Deep Origin co-founders Michael Antonov and Garegin Papoian on why they are betting on physics-based simulation alongside machine learning to make computational drug discovery actually work.
ConcertAI CEO Jeff Elton on how the company built a leading position in real-world oncology data, and what that data makes possible for cancer research and patient care.